1Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation,2003,107:2227-2232.
2Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA,2002,287:1308-1320.
3Seiler C, Hess OM, Schoenbeck M, et al.Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol,1991,17:634-643.
5Walker WS, Reid KC, Cameron EW, et al. Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg, 1989,48:528-535.
6Krajcer Z, Leachman RD, Cooley DA. Mitral valve replacement and septal myomyectomy in hypertrophic cardiomyopathy: Ten-year follow-up in 80 patients. Circulation,1988,78:I35-43.
7Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (MPATHY ). Circulation,1999,99:2927-2933.
8Shamim W, Yousufuddin M, Wang D, et al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med,2002,347:1326-1333.
9Nagueh SF, Ommen SR, Lakkis NM,et al. Comparison of ethanol septal reductiontherapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol,2001,38:1701-1706.
